Several pro-survival and oncogenic pathways, such as, for example, STAT3 and PI3K/AKT/mTOR, can be activated by KSHV proteins, making this lymphoma particularly aggressive and difficult to treat [29]. The gene discussed is MTOR; the disease is lymphoma.